Yesterday, May 31, 2016, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $64.80 to $5,125,908.56.

Highlighted Stocks Traded by Insiders:

Sprouts Farmers Market (SFM) - FREE Research Report

Lukow Bradley, who is Chief Financial Officer at Sprouts Farmers Market, bought 10,000 shares at $25.15 on May 31, 2016. Following this transaction, the Chief Financial Officer owned 28,525 shares meaning that the stake was boosted by 53.98% with the 10,000-share transaction.

The shares most recently traded at $25.03, down $0.12, or 0.5% since the insider transaction. Historical insider transactions for Sprouts Farmers Market go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 12,505

The average volume for Sprouts Farmers Market has been 1.9 million shares per day over the past 30 days. Sprouts Farmers Market has a market cap of $3.7 billion and is part of the services sector and retail industry. Shares are down 6.88% year-to-date as of the close of trading on Tuesday.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company has a P/E ratio of 27.9. Currently, there are 9 analysts who rate Sprouts Farmers Market a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SFM - FREE

TheStreet Quant Ratings rates Sprouts Farmers Market as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Sprouts Farmers Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Fred's (FRED) - FREE Research Report

Hayes Michael, who is Director at Fred's, sold 5,000 shares at $14.68 on May 31, 2016. Following this transaction, the Director owned 1.6 million shares meaning that the stake was reduced by 0.31% with the 5,000-share transaction.

Holligan Mike, who is Evp at Fred's, sold 1,517 shares at $14.67 on May 31, 2016. Following this transaction, the Evp owned 5,900 shares meaning that the stake was reduced by 20.45% with the 1,517-share transaction.

The shares most recently traded at $14.40, down $0.27, or 1.87% since the insider transaction. Historical insider transactions for Fred's go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 10,000

The average volume for Fred's has been 170,900 shares per day over the past 30 days. Fred's has a market cap of $545.5 million and is part of the services sector and retail industry. Shares are down 10.32% year-to-date as of the close of trading on Tuesday.

Fred's, Inc., together with its subsidiaries, sells general merchandise through its retail discount stores and full service pharmacies. The stock currently has a dividend yield of 1.64%. Currently, there are no analysts who rate Fred's a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FRED - FREE

TheStreet Quant Ratings rates Fred's as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Fred's Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medical Properties (MPW) - FREE Research Report

Kellett Sherry A, who is Director at Medical Properties, sold 24,000 shares at $14.46 on May 31, 2016. Following this transaction, the Director owned 57,617 shares meaning that the stake was reduced by 29.41% with the 24,000-share transaction.

The shares most recently traded at $14.66, up $0.20, or 1.36% since the insider transaction. Historical insider transactions for Medical Properties go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 50,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 450,627
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 450,627

The average volume for Medical Properties has been 2.3 million shares per day over the past 30 days. Medical Properties has a market cap of $3.5 billion and is part of the financial sector and real estate industry. Shares are up 27.72% year-to-date as of the close of trading on Tuesday.

Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The stock currently has a dividend yield of 6.28%. The company has a P/E ratio of 20.9. Currently, there is 1 analyst who rates Medical Properties a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPW - FREE

TheStreet Quant Ratings rates Medical Properties as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Medical Properties Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.